Target intelligence / Profile preview

Opportunistic intestinal pathogens

Molecular classification
Other
01

Overview

The term "opportunistic intestinal pathogens" refers collectively to various microorganisms, including bacteria (e.g., *Clostridioides difficile*, *Escherichia coli*, *Staphylococcus aureus*, *Pseudomonas aeruginosa*), fungi (e.g., *Candida albicans*), viruses, and parasites, that rarely cause disease in immunocompetent hosts but are capable of causing significant infections in individuals with weakened immune defenses or altered gut environments[2][3][4]. These organisms may be part of the normal intestinal flora or acquired from the environment or healthcare settings, and they become pathogenic ("opportunistic") when host resistance is compromised (due to diseases such as HIV/AIDS, malignancies, transplantation, or broad-spectrum antibiotic use)[1][2][3][4]. The clinical manifestations depend on the specific microorganism and may include diarrhea, colitis, sepsis, or other gastrointestinal symptoms or systemic infections. Prevention and treatment focus on immune support, cautious antimicrobial use, and, when necessary, direct targeting of the causative pathogen with appropriate drugs[2][4].

Other names
Opportunistic gut pathogensOpportunistic enteric pathogensOpportunistic gastrointestinal pathogens
02

Biological functions

InfectionColonizationPotential commensalism
03

Disease associations

InfectionHospital-acquired infectionSuperinfection after antibioticsDiarrheaInflammation
04

Safety considerations

Antimicrobial resistanceDifficult eradication in immunosuppressed individualsOvergrowth after antibiotic useCan cause severe disease in vulnerable hosts

Beyond the preview

Go deeper on Opportunistic intestinal pathogens.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Opportunistic intestinal pathogens.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call